CAM
SYRS

Cormorant Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Cormorant Asset Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-29,630
Closed -$2.88M – 56
2017
Q4 		$2.88M Hold
29,630
– – 0.3% 44
2017
Q3 		$4.36M Hold
29,630
– – 0.77% 36
2017
Q2 		$4.77M Buy
+29,630
New +$4.77M 0.79% 36